1. Home
  2. NRIX vs XE Comparison

NRIX vs XE Comparison

Compare NRIX & XE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$14.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo X-Energy Inc. Class A Common Stock

XE

X-Energy Inc. Class A Common Stock

SELL

Current Price

$10.30

Market Cap

3.1B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
NRIX
XE
Founded
2009
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.1B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
NRIX
XE
Price
$14.76
$10.30
Analyst Decision
Buy
Buy
Analyst Count
14
11
Target Price
★ $33.50
$25.72
AVG Volume (30 Days)
3.4M
★ 5.6M
Earning Date
10-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 3.26
N/A
Revenue
★ $76,987,000.00
N/A
Revenue This Year
$786.93
$132.70
Revenue Next Year
N/A
$293.45
P/E Ratio
$4.52
★ N/A
Revenue Growth
★ 99.31
N/A
52 Week Low
$12.61
$8.68
52 Week High
$28.23
$23.99

Technical Indicators

Market Signals
Indicator
NRIX
XE
Relative Strength Index (RSI) 25.08 40.67
Support Level $14.65 $10.04
Resistance Level $17.47 $12.08
Average True Range (ATR) 1.22 0.95
MACD -0.77 0.20
Stochastic Oscillator 0.23 46.91

Price Performance

Historical Comparison
NRIX
XE

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About XE X-Energy Inc. Class A Common Stock

X-Energy Inc operates as a designer of small modular nuclear reactors (SMRs) and nuclear fuel technologies. Its products include the Xe-100 high-temperature gas-cooled reactor and TRISO-X particle fuel, which are being developed for applications in grid power, industrial facilities, and artificial intelligence infrastructure.

Share on Social Networks: